# Webstar Technology Group Inc.: financial statements, quarterly

WBSR · OTC · CIK 1645155 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/wbsr.md) · [Financials](/companies/wbsr/financials.md) · [Filings](/companies/wbsr/filings.md) · [Insiders](/companies/wbsr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/wbsr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [(0.2)](/filings/0001493152-24-033075.md) | [(0.2)](/filings/0001493152-24-045418.md) | [(0.2) d](/filings/0001641172-25-008374.md) | [(0.2)](/filings/0001641172-25-018716.md) | [(0.2)](/filings/0001493152-25-012030.md) | [(0.0)](/filings/0001493152-25-023335.md) | [(0.0) d](/filings/0001493152-26-047641.md) | [(0.0)](/filings/0001493152-26-024594.md) | [(0.1)](/filings/0001493152-25-012030.md) | [(0.1)](/filings/0001493152-25-023335.md) | [(3.5) d](/filings/0001493152-26-047641.md) | [(0.2)](/filings/0001493152-26-024594.md) |
| Interest expense | $m | [0.0](/filings/0001493152-23-027791.md) | not reported | not reported | not reported | [0.0](/filings/0001493152-25-012030.md) | [0.0](/filings/0001493152-25-023335.md) | not reported | not reported | [0.0](/filings/0001493152-25-012030.md) | [0.0](/filings/0001493152-25-023335.md) | not reported | not reported |
| Net income | $m | [(0.2)](/filings/0001493152-24-045418.md) | [(0.2)](/filings/0001493152-24-045418.md) | [(0.2) d](/filings/0001641172-25-008374.md) | [(0.2)](/filings/0001493152-25-012030.md) | [(4.2)](/filings/0001493152-25-012030.md) | [(0.0)](/filings/0001493152-25-023335.md) | [(14.7) d](/filings/0001493152-26-047641.md) | [(0.1)](/filings/0001493152-26-024594.md) | [(0.1)](/filings/0001493152-25-012030.md) | [(0.2)](/filings/0001493152-25-023335.md) | [(0.7) d](/filings/0001493152-26-047641.md) | [(1.3)](/filings/0001493152-26-024594.md) |
| Diluted EPS | $ per share | [0.00](/filings/0001493152-24-033075.md) | [0.00](/filings/0001493152-24-045418.md) | not reported | [0.00](/filings/0001641172-25-018716.md) | [(0.03)](/filings/0001493152-25-012030.md) | [0.00](/filings/0001493152-25-023335.md) | not reported | [0.00](/filings/0001493152-26-024594.md) | [0.00](/filings/0001493152-25-012030.md) | [0.00](/filings/0001493152-25-023335.md) | not reported | [0.00](/filings/0001493152-26-024594.md) |
| Basic EPS | $ per share | [0.00](/filings/0001493152-24-033075.md) | [0.00](/filings/0001493152-24-045418.md) | not reported | [0.00](/filings/0001641172-25-018716.md) | [(0.03)](/filings/0001493152-25-012030.md) | [0.00](/filings/0001493152-25-023335.md) | not reported | [0.00](/filings/0001493152-26-024594.md) | [0.00](/filings/0001493152-25-012030.md) | [0.00](/filings/0001493152-25-023335.md) | not reported | [0.00](/filings/0001493152-26-024594.md) |

- Revenue: not reported
- Cost of revenue: not reported
- Gross profit: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.0](/filings/0001493152-23-027791.md) | [0.0](/filings/0001493152-23-040386.md) | [0.0](/filings/0001641172-25-008374.md) | [0.0](/filings/0001493152-24-018651.md) | [0.0](/filings/0001493152-24-033075.md) | [0.0](/filings/0001493152-24-045418.md) | [0.0](/filings/0001641172-25-008374.md) | [0.0](/filings/0001641172-25-018716.md) | [0.0](/filings/0001493152-25-012030.md) | [0.0](/filings/0001493152-25-023335.md) | [0.0](/filings/0001493152-26-016894.md) | [0.0](/filings/0001493152-26-024594.md) |
| Current assets | $m | [0.0](/filings/0001493152-23-027791.md) | [0.0](/filings/0001493152-23-040386.md) | [0.0](/filings/0001641172-25-008374.md) | [0.0](/filings/0001493152-24-018651.md) | [0.0](/filings/0001493152-24-033075.md) | [0.0](/filings/0001493152-24-045418.md) | [0.0](/filings/0001493152-26-047641.md) | [0.0](/filings/0001641172-25-018716.md) | [0.1](/filings/0001493152-25-012030.md) | [0.5](/filings/0001493152-25-023335.md) | [0.1](/filings/0001493152-26-047641.md) | [38.1](/filings/0001493152-26-024594.md) |
| Total assets | $m | [0.0](/filings/0001493152-23-027791.md) | [0.0](/filings/0001493152-23-040386.md) | [0.0](/filings/0001641172-25-008374.md) | not reported | not reported | not reported | [0.0](/filings/0001493152-26-047641.md) | [0.0](/filings/0001641172-25-018716.md) | [0.2](/filings/0001493152-25-012030.md) | [0.6](/filings/0001493152-25-023335.md) | [35.1](/filings/0001493152-26-047641.md) | [38.1](/filings/0001493152-26-024594.md) |
| Current liabilities | $m | [3.0](/filings/0001493152-23-027791.md) | [3.2](/filings/0001493152-23-040386.md) | [4.4](/filings/0001641172-25-008374.md) | [4.6](/filings/0001493152-24-018651.md) | [1.0](/filings/0001493152-24-033075.md) | [1.1](/filings/0001493152-24-045418.md) | [19.8](/filings/0001493152-26-047641.md) | [1.1](/filings/0001641172-25-018716.md) | [1.3](/filings/0001493152-25-012030.md) | [1.9](/filings/0001493152-25-023335.md) | [55.5](/filings/0001493152-26-047641.md) | [40.5](/filings/0001493152-26-024594.md) |
| Total liabilities | $m | [4.0](/filings/0001493152-23-027791.md) | [4.2](/filings/0001493152-23-040386.md) | [4.4](/filings/0001493152-24-011912.md) | not reported | not reported | not reported | [19.8](/filings/0001493152-26-047641.md) | not reported | not reported | not reported | [56.2](/filings/0001493152-26-047641.md) | [41.8](/filings/0001493152-26-024594.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001641172-25-018716.md) | [0.0](/filings/0001641172-25-018716.md) | not reported | [0.2](/filings/0001493152-25-023335.md) | [0.2](/filings/0001493152-26-047641.md) | [0.9](/filings/0001493152-26-024594.md) |
| Shareholders' equity | $m | [(3.9)](/filings/0001493152-24-045418.md) | [(4.2)](/filings/0001493152-24-045418.md) | [(4.4)](/filings/0001493152-26-016894.md) | [(4.6)](/filings/0001493152-25-012030.md) | [(1.0)](/filings/0001493152-25-012030.md) | [(1.0)](/filings/0001493152-24-045418.md) | [(19.8)](/filings/0001493152-26-047641.md) | [(1.1)](/filings/0001493152-25-012030.md) | [(1.1)](/filings/0001493152-25-012030.md) | [(1.3)](/filings/0001493152-25-023335.md) | [(20.7)](/filings/0001493152-26-047641.md) | [(3.5)](/filings/0001493152-26-024594.md) |

- Cash and equivalents: us-gaap:Cash, us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(58.5) d](/filings/0001493152-24-033075.md) | [(14.5) d](/filings/0001493152-24-045418.md) | [(3.5) d](/filings/0001641172-25-008374.md) | [(2.1)](/filings/0001641172-25-018716.md) | [(0.0) d](/filings/0001493152-25-012030.md) | [0.0 d](/filings/0001493152-25-023335.md) | [(110) d](/filings/0001493152-26-047641.md) | [(31.3)](/filings/0001493152-26-024594.md) | [(97.3) d](/filings/0001493152-25-012030.md) | [(533) d](/filings/0001493152-25-023335.md) | [644 d](/filings/0001493152-26-047641.md) | [(513)](/filings/0001493152-26-024594.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

## Shares

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [150](/filings/0001493152-24-033075.md) | [158](/filings/0001493152-24-045418.md) | [158](/filings/0001641172-25-018716.md) | [166](/filings/0001493152-25-012030.md) | [201](/filings/0001493152-25-023335.md) | [402](/filings/0001493152-26-024594.md) | [402](/filings/0001493152-25-012030.md) | [404](/filings/0001493152-25-023335.md) | [405](/filings/0001493152-26-024594.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 406,558,604 at 2026-10-07, from the cover of the [10-K/A filed 2026-10-20](/filings/0001493152-26-047641.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.